📣 ActiGraph Acquires Biofourmis Life Science Business

Actigraph + Biofourmisz

The Biofourmis Connect life science platform is now part of ActiGraph’s Digital Health Technology ecosystem

Modernizing Clinical Research Through Digital Transformation

We are empowering biopharma companies to unleash the potential of big data and AI with a device-agnostic, decentralized trial platform backed by ActiGraph’s proven operational, scientific, and regulatory expertise.

Accelerate clinical trial modernization with streamlined collection of continuous, high precision data centered on the patient.

Read the Announcement

 

Device Agnostic Platform

Device Agnostic Platform

A suite of connected devices and sensors – not just ActiGraph devices – enable remote and real-time collection of continuous, high-precision digital health data.

  • Capture a much wider variety of digital data through a single connected platform, supported by ActiGraph’s proven data science and operational expertise
  • Sensor solutions include ECG patch, pulse oximetry, spirometer, blood pressure, and wrist-worn actigraphy.
Risk Prediction for Oncology and Immunology Trials

Risk Prediction for Oncology and Immunology Trials

Remote patient monitoring platform and AI-powered risk monitoring enable more effective trial designs that improve the speed, cost-effectiveness, and the patient-centric nature of trials.

  • Unlock clinical decision support with algorithm-enabled metrics and real-time data access
  • Detect and predict adverse events such as cytokine release syndrome (CRS) and neurotoxicity through AI-powered analysis and remote patient monitoring platform
Digital Measures, Biomarkers and Endpoints

Digital Measures, Biomarkers and Endpoints

Capture continuous, high precision data across multiple measurement domains to address unmet measurement need with one of the most extensive libraries of digital measures in the industry.

  • Improve measurement precision with continuous and episodic data collection enabled by our device-agnostic ecosystem of wearable sensors
  • Address unmet measurement needs with digital biomarker and endpoint development, such as an objective measure for pain
  • Advance your clinical development program with expert guidance through algorithm design, validation, and roadmap towards regulatory clearance (SaMD)
Digital Clinical Trials

Digital Clinical Trials

The Connect platform is poised to deliver the most comprehensive and trusted digital health solutions to the life science industry.

  • Improve participant engagement and compliance and enhance data quality with continuous, remote data collection
  • Reduce operational burden and streamline access to trial data through a user-friendly dashboard, integrated communications, and optimized resource coordination
Continuous Remote Monitoring

Continuous Remote Monitoring

Continuous, remote digital data collection, FDA-cleared algorithms, and real-time data access enable modeling of participant baseline measures to enable individualized disease state monitoring.

  • Easy to use system with integrated communication channels improves the trial experience for participants and sites
  • Gain a more comprehensive view of treatment impact on vital signs and behavior with continuous, remote data collection